ONCTERNAL THERAPEUTICS INC - COM (ONCT)

CUSIP: 68236P107

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / COM
Total 13F shares
9,366,691
Share change
-280,727
Total reported value
$9,307,125
Put/Call ratio
5.1%
Price per share
$1.00
Number of holders
58
Value change
-$262,531
Number of buys
23
Number of sells
22

Quarterly Holders Quick Answers

What is CUSIP 68236P107?
CUSIP 68236P107 identifies ONCT - ONCTERNAL THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ONCTERNAL THERAPEUTICS INC - COM (ONCT) as of Q4 2022

As of 31 Dec 2022, ONCTERNAL THERAPEUTICS INC - COM (ONCT) was held by 58 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,366,691 shares. The largest 10 holders included VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, BlackRock Inc., BIT Capital GmbH, Quantum Private Wealth, LLC, GEODE CAPITAL MANAGEMENT, LLC, BRIGHTON JONES LLC, KENNEDY CAPITAL MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, and ACADIAN ASSET MANAGEMENT LLC. This page lists 58 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.